{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T06:03:36Z","timestamp":1771221816752,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,15]]},"DOI":"10.7759\/cureus.103681","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T05:11:37Z","timestamp":1771218697000},"source":"Crossref","is-referenced-by-count":0,"title":["Natural Polyphenols Versus Standard Therapy: Effects on Neuroinflammation and Alpha-Synuclein Expression in a 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Induced Mouse Model of Parkinson\u2019s Disease"],"prefix":"10.7759","author":[{"given":"Shalini","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karan","family":"Suneja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ipshita","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suyog","family":"Sindhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satyendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishi","family":"Pal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra","family":"Nath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson's disease","volume":"20","author":"Tolosa E","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in the diagnosis of Parkinson's disease. Lancet Neurol. 2021, 20:385-97. 10.1016\/S1474-4422(21)00030-2","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.14802\/jmd.24075","article-title":"\u03b1-Synuclein: a promising biomarker for Parkinson's disease and related disorders","volume":"17","author":"Hatano T","year":"2024","unstructured":"Hatano T, Okuzumi A, Matsumoto G, Tsunemi T, Hattori N. \u03b1-Synuclein: a promising biomarker for Parkinson's disease and related disorders. J Mov Disord. 2024, 17:127-37. 10.14802\/jmd.24075","journal-title":"J Mov Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14101154","article-title":"Involvement of neuroinflammation and oxidative stress in L-DOPA-induced dyskinesia in Parkinson's disease: role of renin-angiotensin system and ROCK pathway","volume":"14","author":"Mu\u00f1oz A","year":"2025","unstructured":"Mu\u00f1oz A, L\u00f3pez-L\u00f3pez A, Rodr\u00edguez-Pallares J, Labandeira-Garcia JL. Involvement of neuroinflammation and oxidative stress in L-DOPA-induced dyskinesia in Parkinson's disease: role of renin-angiotensin system and ROCK pathway. Antioxidants (Basel). 2025, 14:10.3390\/antiox14101154","journal-title":"Antioxidants (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00914-0","article-title":"Diagnostic biomarkers for \u03b1-synucleinopathies- state of the art and future developments: a systematic review","volume":"21","author":"Donadio V","year":"2025","unstructured":"Donadio V, Ingelsson M, Rizzo G, et al.. Diagnostic biomarkers for \u03b1-synucleinopathies- state of the art and future developments: a systematic review. Mol Neurodegener. 2025, 21:1. 10.1186\/s13024-025-00914-0","journal-title":"Mol Neurodegener"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/NRR.NRR-D-24-01539","article-title":"Neuroinflammation in neurodegenerative diseases: focusing on the mediation of T lymphocytes","volume":"21","author":"Li K","year":"2026","unstructured":"Li K, Chen R, Wang R, Fan W, Zhao N, Yang Z, Yan J. Neuroinflammation in neurodegenerative diseases: focusing on the mediation of T lymphocytes. Neural Regen Res. 2026, 21:1864-89. 10.4103\/NRR.NRR-D-24-01539","journal-title":"Neural Regen Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-025-01158-x","article-title":"Inhibition of T cell infiltration and soluble TNF signaling is neuroprotective in the alpha-synuclein overexpressing mouse model of Parkinson's disease","volume":"11","author":"Tavira A","year":"2025","unstructured":"Tavira A, Basurco L, Abellanas MA, et al.. Inhibition of T cell infiltration and soluble TNF signaling is neuroprotective in the alpha-synuclein overexpressing mouse model of Parkinson's disease. NPJ Parkinsons Dis. 2025, 11:315. 10.1038\/s41531-025-01158-x","journal-title":"NPJ Parkinsons Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.70034","article-title":"The roles of neuroinflammation in L-DOPA-induced dyskinesia: dissecting the roles of NF-\u03baB and TNF-\u03b1 for novel pharmacological therapeutic approaches","volume":"61","author":"Zamanian MY","year":"2025","unstructured":"Zamanian MY, Golmohammadi M, Gardanova ZR, Rahimi M, Khachatryan LG, Khazaei M. The roles of neuroinflammation in L-DOPA-induced dyskinesia: dissecting the roles of NF-\u03baB and TNF-\u03b1 for novel pharmacological therapeutic approaches. Eur J Neurosci. 2025, 61:e70034. 10.1111\/ejn.70034","journal-title":"Eur J Neurosci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2019.03.043","article-title":"Resveratrol synergizes with low doses of L-DOPA to improve MPTP-induced Parkinson disease in mice","volume":"367","author":"Liu Q","year":"2019","unstructured":"Liu Q, Zhu D, Jiang P, et al.. Resveratrol synergizes with low doses of L-DOPA to improve MPTP-induced Parkinson disease in mice. Behav Brain Res. 2019, 367:10-8. 10.1016\/j.bbr.2019.03.043","journal-title":"Behav Brain Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.37349\/ent.2025.1004124","article-title":"Resveratrol\u2019s potential in the prevention and treatment of neurodegenerative diseases: molecular mechanisms","volume":"5","author":"Costa MDRd","year":"2025","unstructured":"Costa MDRd, Teixeira IMM, Duque BR et. al. Resveratrol\u2019s potential in the prevention and treatment of neurodegenerative diseases: molecular mechanisms. Explor Neuroprot Ther. 2025, 5:1-16. 10.37349\/ent.2025.1004124","journal-title":"Explor Neuroprot Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1198335","article-title":"Curcumin alleviates 1-methyl- 4-phenyl- 1,2,3,6-tetrahydropyridine- induced Parkinson's disease in mice via modulating gut microbiota and short-chain fatty acids","volume":"14","author":"Cai B","year":"2023","unstructured":"Cai B, Zhong L, Wang Q, Xu W, Li X, Chen T. Curcumin alleviates 1-methyl- 4-phenyl- 1,2,3,6-tetrahydropyridine- induced Parkinson's disease in mice via modulating gut microbiota and short-chain fatty acids. Front Pharmacol. 2023, 14:1198335. 10.3389\/fphar.2023.1198335","journal-title":"Front Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e34082","article-title":"Time association study on a sub-acute mouse model of Parkinson's disease","volume":"10","author":"Ren J","year":"2024","unstructured":"Ren J, Liu T, You L, et al.. Time association study on a sub-acute mouse model of Parkinson's disease. Heliyon. 2024, 10:e34082. 10.1016\/j.heliyon.2024.e34082","journal-title":"Heliyon"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1464706","article-title":"Behavioral analysis of motor and non-motor impairment in rodent models of Parkinson's disease","volume":"16","author":"Sheta R","year":"2024","unstructured":"Sheta R, B\u00e9rard M, Musiol D, Mart\u00ednez-Drudis L, Oueslati A. Behavioral analysis of motor and non-motor impairment in rodent models of Parkinson's disease. Front Aging Neurosci. 2024, 16:1464706. 10.3389\/fnagi.2024.1464706","journal-title":"Front Aging Neurosci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-017-1922-x","article-title":"Neuroprotective properties of curcumin in toxin-base animal models of Parkinson's disease: a systematic experiment literatures review","volume":"17","author":"Wang XS","year":"2017","unstructured":"Wang XS, Zhang ZR, Zhang MM, Sun MX, Wang WW, Xie CL. Neuroprotective properties of curcumin in toxin-base animal models of Parkinson's disease: a systematic experiment literatures review. BMC Complement Altern Med. 2017, 17:412. 10.1186\/s12906-017-1922-x","journal-title":"BMC Complement Altern Med"},{"key":"ref14","unstructured":"Compendium of CCSEA. (2018). https.\/\/ccsea.gov.in\/WriteReadData\/userfiles\/file\/Compendium%20of%20CPCSEA.pdf."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2025.04.053","article-title":"Taurochenodeoxycholic acid activates autophagy and suppresses inflammatory responses in microglia of MPTP-induced Parkinson's disease mice via AMPK\/mTOR, AKT\/NF\u03baB and Pink1\/Parkin signaling pathways mediated by Takeda G protein-coupled receptor 5","volume":"235","author":"Ni C","year":"2025","unstructured":"Ni C, Wang L, Bai Y, et al.. Taurochenodeoxycholic acid activates autophagy and suppresses inflammatory responses in microglia of MPTP-induced Parkinson's disease mice via AMPK\/mTOR, AKT\/NF\u03baB and Pink1\/Parkin signaling pathways mediated by Takeda G protein-coupled receptor 5. Free Radic Biol Med. 2025, 235:347-63. 10.1016\/j.freeradbiomed.2025.04.053","journal-title":"Free Radic Biol Med"},{"key":"ref16","unstructured":"Parkinson disease. (2025). Accessed. September 15, 2025: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470193\/."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2016.07.002","article-title":"Expanding the repertoire of L-DOPA's actions: a comprehensive review of its functional neurochemistry","volume":"151","author":"De Deurwaerd\u00e8re P","year":"2017","unstructured":"De Deurwaerd\u00e8re P, Di Giovanni G, Millan MJ. Expanding the repertoire of L-DOPA's actions: a comprehensive review of its functional neurochemistry. Prog Neurobiol. 2017, 151:57-100. 10.1016\/j.pneurobio.2016.07.002","journal-title":"Prog Neurobiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.644219","article-title":"Resveratrol in rodent models of Parkinson's disease: a systematic review of experimental studies","volume":"12","author":"Su CF","year":"2021","unstructured":"Su CF, Jiang L, Zhang XW, Iyaswamy A, Li M. Resveratrol in rodent models of Parkinson's disease: a systematic review of experimental studies. Front Pharmacol. 2021, 12:644219. 10.3389\/fphar.2021.644219","journal-title":"Front Pharmacol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/ph16010039","article-title":"Exploring the neuroprotective mechanism of curcumin inhibition of intestinal inflammation against Parkinson's disease based on the gut-brain axis","volume":"16","author":"Zhong L","year":"2022","unstructured":"Zhong L, Cai B, Wang Q, Li X, Xu W, Chen T. Exploring the neuroprotective mechanism of curcumin inhibition of intestinal inflammation against Parkinson's disease based on the gut-brain axis. Pharmaceuticals (Basel). 2022, 16:10.3390\/ph16010039","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/neup.12812","article-title":"Neuropathology of \u03b1-synuclein in Parkinson's disease","volume":"42","author":"Choong CJ","year":"2022","unstructured":"Choong CJ, Mochizuki H. Neuropathology of \u03b1-synuclein in Parkinson's disease. Neuropathology. 2022, 42:93-103. 10.1111\/neup.12812","journal-title":"Neuropathology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/461601-natural-polyphenols-versus-standard-therapy-effects-on-neuroinflammation-and-alpha-synuclein-expression-in-a-1-methyl-4-phenyl-1236-tetrahydropyridine-mptp-induced-mouse-model-of-parkinsons-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T05:11:38Z","timestamp":1771218698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/461601-natural-polyphenols-versus-standard-therapy-effects-on-neuroinflammation-and-alpha-synuclein-expression-in-a-1-methyl-4-phenyl-1236-tetrahydropyridine-mptp-induced-mouse-model-of-parkinsons-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,15]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.103681","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,15]]}}}